Sebetralstat (KVD900)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sebetralstat (KVD900), covering 2024-07-19 to 2024-07-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE) [Phase 3]